AU1687500A - Antihuman vegf monoclonal antibody - Google Patents

Antihuman vegf monoclonal antibody

Info

Publication number
AU1687500A
AU1687500A AU16875/00A AU1687500A AU1687500A AU 1687500 A AU1687500 A AU 1687500A AU 16875/00 A AU16875/00 A AU 16875/00A AU 1687500 A AU1687500 A AU 1687500A AU 1687500 A AU1687500 A AU 1687500A
Authority
AU
Australia
Prior art keywords
monoclonal antibody
vegf monoclonal
antihuman
antihuman vegf
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU16875/00A
Other languages
English (en)
Inventor
Nobuo Hanai
Mikito Ito
Junji Kanazawa
Masabumi Shibuya
Kenya Shitara
Tatsuya Tamaoki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Publication of AU1687500A publication Critical patent/AU1687500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
AU16875/00A 1998-12-16 1999-12-16 Antihuman vegf monoclonal antibody Abandoned AU1687500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP35714898 1998-12-16
JP10/357148 1998-12-16
PCT/JP1999/007074 WO2000035956A1 (fr) 1998-12-16 1999-12-16 Anticorps monoclonal anti-vegf humain

Publications (1)

Publication Number Publication Date
AU1687500A true AU1687500A (en) 2000-07-03

Family

ID=18452629

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16875/00A Abandoned AU1687500A (en) 1998-12-16 1999-12-16 Antihuman vegf monoclonal antibody

Country Status (2)

Country Link
AU (1) AU1687500A (fr)
WO (1) WO2000035956A1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3850299A (en) * 1998-05-20 1999-12-06 Kyowa Hakko Kogyo Co. Ltd. Vegf activity inhibitors
AR045563A1 (es) * 2003-09-10 2005-11-02 Warner Lambert Co Anticuerpos dirigidos a m-csf
TW200812615A (en) 2006-03-22 2008-03-16 Hoffmann La Roche Tumor therapy with an antibody for vascular endothelial growth factor and an antibody for human epithelial growth factor receptor type 2
NZ574580A (en) 2006-08-21 2011-12-22 Hoffmann La Roche Her2 tumor therapy with an anti-vegf antibody
US9266967B2 (en) 2007-12-21 2016-02-23 Hoffmann-La Roche, Inc. Bivalent, bispecific antibodies
US20090162359A1 (en) 2007-12-21 2009-06-25 Christian Klein Bivalent, bispecific antibodies
US8268314B2 (en) 2008-10-08 2012-09-18 Hoffmann-La Roche Inc. Bispecific anti-VEGF/anti-ANG-2 antibodies
JP5501439B2 (ja) 2009-04-02 2014-05-21 ロシュ グリクアート アクチェンゲゼルシャフト 完全長抗体と単鎖Ｆａｂフラグメントとを含む多重特異的抗体
KR101456326B1 (ko) 2009-04-07 2014-11-12 로슈 글리카트 아게 3가, 이중특이적 항체
US9676845B2 (en) 2009-06-16 2017-06-13 Hoffmann-La Roche, Inc. Bispecific antigen binding proteins
CN104945509A (zh) 2009-09-16 2015-09-30 弗·哈夫曼-拉罗切有限公司 包含卷曲螺旋和/或系链的蛋白质复合体及其用途
AR080794A1 (es) 2010-03-26 2012-05-09 Hoffmann La Roche Anticuerpos bivalentes biespecificos anti- vegf/ anti-ang-2
TW201138821A (en) 2010-03-26 2011-11-16 Roche Glycart Ag Bispecific antibodies
TW201208703A (en) 2010-08-17 2012-03-01 Roche Glycart Ag Combination therapy of an afucosylated CD20 antibody with an anti-VEGF antibody
CN103068846B9 (zh) 2010-08-24 2016-09-28 弗·哈夫曼-拉罗切有限公司 包含二硫键稳定性Fv片段的双特异性抗体
EP2655413B1 (fr) 2010-12-23 2019-01-16 F.Hoffmann-La Roche Ag Complexe polypeptide-polynucléotide et son utilisation dans l'administration d'une fraction effectrice ciblée
EP2681239B8 (fr) 2011-02-28 2015-09-09 F. Hoffmann-La Roche AG Protéines de liaison à un antigène
EP2681240B1 (fr) 2011-02-28 2017-08-16 F. Hoffmann-La Roche AG Protéines monovalentes de liaison à l'antigène
BR112014019579A2 (pt) 2012-02-10 2019-10-15 Genentech, Inc Anticorpo de cadeia única, polinucleotídeo, vetor, célula hospedeira, método de produção de um anticorpo de cadeia única, heteromultímero e método de produção do heteromultímero
WO2014001325A1 (fr) 2012-06-27 2014-01-03 F. Hoffmann-La Roche Ag Méthode de fabrication de conjugués d'anticorps à région fc comprenant au moins une entité de liaison qui se lie spécifiquement à une cible et leurs utilisations
RU2639287C2 (ru) 2012-06-27 2017-12-20 Ф. Хоффманн-Ля Рош Аг Способ отбора и получения высокоселективных и мультиспецифичных нацеливающих групп с заданными свойствами, включающих по меньшей мере две различные связывающие группировки, и их применения
JP6154900B2 (ja) 2012-07-13 2017-06-28 ロシュ グリクアート アクチェンゲゼルシャフト 二重特異性抗ｖｅｇｆ／抗ａｎｇ−２抗体及び眼血管疾患の処置におけるそれらの使用
CN104341504B (zh) 2013-08-06 2017-10-24 百奥泰生物科技(广州)有限公司 双特异性抗体
WO2015052230A1 (fr) 2013-10-11 2015-04-16 F. Hoffmann-La Roche Ag Anticorps à chaîne légère variable commune échangée à domaine multispécifique
ES2764111T3 (es) 2014-12-03 2020-06-02 Hoffmann La Roche Anticuerpos multiespecíficos
CN111479588A (zh) 2017-12-29 2020-07-31 豪夫迈·罗氏有限公司 用于改善抗vegf抗体的vegf受体阻断选择性的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5730977A (en) * 1995-08-21 1998-03-24 Mitsui Toatsu Chemicals, Inc. Anti-VEGF human monoclonal antibody
JPH10245347A (ja) * 1997-02-28 1998-09-14 Toagosei Co Ltd 体液再貯留抑制剤

Also Published As

Publication number Publication date
WO2000035956A1 (fr) 2000-06-22

Similar Documents

Publication Publication Date Title
AU1687500A (en) Antihuman vegf monoclonal antibody
AU4042195A (en) Anti-alphaV-integrin monoclonal antibody
DE69920897D1 (de) Monoklonale antikörper mit verringerter immunisierungsfähigkeit
AU1462300A (en) Human pan-hcv human monoclonal antibodies
AU7863794A (en) Antihuman tyrosinase monoclonal antibody
IL128406A0 (en) Monoclonal antibodies
HUP0300841A3 (en) Agonist anti-trk-c monoclonal antibodies
EP1071458A4 (fr) Anticorps humanises et utilisations correspondantes
AU8432498A (en) Human-cd28 specific monoclonal antibodies for antigen non-specific activation oft-lymphocytes
AU1550300A (en) Antigen-binding proteins
AU2002220843A1 (en) Humanised antibodies and uses thereof
IL147517A0 (en) Monoclonal antibodies and immunoassay utilizing the same
AU6702998A (en) Anti-alphabeta3 humanized monoclonal antibodies
AU1598801A (en) HGF-SF monoclonal antibody combinations
AU7072998A (en) Immunoassays using anti-allotypic monoclonal antibodies
AU2645297A (en) Hepatitis b monoclonal antibodies
IL132139A0 (en) Anti-fas antibodies
AU5970198A (en) Anti-fas antibodies
AU2596397A (en) Monoclonal antibody that detects apoptotic antigen
AU2001284899A1 (en) Methods and universal monoclonal antibody array
GB9828700D0 (en) Antibody
GB9718911D0 (en) Monoclonal antibodies
EP1106701A4 (fr) Anticorps monoclonal agissant contre la trypsine canine
AUPP259798A0 (en) Monoclonal antibody against hb-egf
AU2002217525A1 (en) Novel monoclonal antibody

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase